Showing results (141-150 of 223) with videos related to

Sort By:
Pageof 23
Scientific Reports|July 30, 2016
Expression of the inhibitory Ly49E receptor is not critically involved in the immune response against cutaneous, pulmonary or liver tumoursJessica Filtjens, Jiri Keirsse, Els Van Ammel, et al.
Frontiers in Immunology|July 5, 2021
A Novel Non-Coding Variant in DCLRE1C Results in Deregulated Splicing and Induces SCID Through the Generation of a Truncated ARTEMIS Protein That Fails to Support V(D)J Recombination and DNA Damage RepairSteven Strubbe, Marieke De Bruyne, Ulrich Pannicke, et al.
Nature Immunology|July 29, 2020
Distinct and temporary-restricted epigenetic mechanisms regulate human αβ and γδ T cell developmentJuliette Roels, Anna Kuchmiy, Matthias De Decker, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 31, 2014
GATA-3 dose-dependent checkpoints in early T cell commitmentDeirdre D Scripture-Adams, Sagar S Damle, Long Li, et al.
Plos One|October 14, 2014
Ly49E expression on CD8αα-expressing intestinal intraepithelial lymphocytes plays no detectable role in the development and progression of experimentally induced inflammatory bowel diseasesAline Van Acker, Jessica Filtjens, Sophie Van Welden, et al.
Genes, Chromosomes & Cancer|July 2, 2022
Multiomics to investigate the mechanisms contributing to repression of PTPRC and SOCS2 in pediatric T-ALL: Focus on miR-363-3p and promoter methylationMonika Drobna-Śledzińska, Natalia Maćkowska-Maślak, Roman Jaksik, et al.
Acta Clinica Belgica|April 15, 2020
Treatment of a patient with severe cytomegalovirus (CMV) infection after haploidentical stem cell transplantation with donor derived CMV specific T cellsJoline Ingels, Saskia De Smet, Kelly Heyns, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 7, 2017
Bcl11b and combinatorial resolution of cell fate in the T-cell gene regulatory networkWilliam J R Longabaugh, Weihua Zeng, Jingli A Zhang, et al.
Haematologica|April 4, 2024
<i>HES6</i>knockdown in human hematopoietic precursor cells reduces their <i>in vivo</i> engraftment potential and their capacity to differentiate into erythroid cells, B cells, T cells and plasmacytoid dendritic cellsTamara De Vos, Nicole Oatman, Lena Boehme, et al.
Oncoimmunology|August 9, 2021
<i>In vitro</i> OP9-DL1 co-culture and subsequent maturation in the presence of IL-21 generates tumor antigen-specific T cells with a favorable less-differentiated phenotype and enhanced functionalitySarah Bonte, Stijn de Munter, Lore Billiet, et al.
Pageof 23